Neil Buckholtz, Ph.D. National Institute on Aging/NIH 70 yo Normal 72 yo MCI 74 yo AD CMRgI Abnormalities in Probable Alzheimer’s Dementia From Reiman et al, New Engl J…
PowerPoint Presentation Alzheimer’s Disease Neuroimaging Initiative December, 2010 1 NEED FOR VALIDATED BIOMARKERS FOR AD TRIALS Biomarkers useful in Phase 2 to make decisions…